Comments from Consumer Healthcare Products Association (CHPA) Regarding Food and Drug Administration (FDA) Commissioner Gottlieb’s Dietary Supplement Statement

The Consumer Healthcare Products Association (CHPA) today issued the following reaction today in response to the Food and Drug Administration (FDA) Commissioner Gottlieb’s statement regarding dietary supplements:

 “CHPA welcomes Commissioner Gottlieb’s comprehensive statement today regarding FDA’s efforts to modernize its oversight of dietary supplements. 

“Millions of Americans use dietary supplements and with increasing consumer demand for these products, we need to be even more vigilant in protecting consumer health while at the same time preserving access. CHPA and our member companies strongly support FDA’s efforts to identify bad actors selling adulterated or misbranded dietary supplement products. We also look forward to collaborating with FDA on proposals to enhance quality and promote informed decision making as well as to discussing with the agency new policies which would promote innovation in the industry.
“The 25th anniversary of the passage of the Dietary Supplement Health and Education Act (DSHEA) is an excellent time to examine processes aimed at ensuring that the products consumers purchase are safe and carry claims backed by evidence, as well as ways to promote innovation in the industry.  This important announcement by FDA highlights the need for balance between continued access to products that promote a healthy lifestyle, fostering research on new, innovative ingredients, and making sure that marketed products are accurately labeled and are safe for use. We look forward to ongoing discussion with the agency to ensure that the goals outlined in Dr. Gottlieb’s statement come to fruition.”  


The Consumer Healthcare Products Association (CHPA) is the 138-year-old national trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines and dietary supplements. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $6-$7, contributing a total of $102 billion in savings each year. CHPA is committed to empowering self-care by preserving and expanding choice and availability of consumer healthcare products.

Contact: Lauren Bloomberg (